0 316

Cited 0 times in

Cited 2 times in

Preclinical activity of NVL-655 in patient-derived models of ALK cancers, including those with lorlatinib-resistant G1202R/L1196M compound mutation

DC Field Value Language
dc.contributor.author조병철-
dc.date.accessioned2023-03-21T07:17:00Z-
dc.date.available2023-03-21T07:17:00Z-
dc.date.issued2022-10-
dc.identifier.issn0959-8049-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/193291-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherElsevier Science Ltd-
dc.relation.isPartOfEUROPEAN JOURNAL OF CANCER-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titlePreclinical activity of NVL-655 in patient-derived models of ALK cancers, including those with lorlatinib-resistant G1202R/L1196M compound mutation-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorT. Fujino-
dc.contributor.googleauthorL. Nguyen-
dc.contributor.googleauthorS. Yoda-
dc.contributor.googleauthorM. Yu-
dc.contributor.googleauthorH. Mizuta-
dc.contributor.googleauthorL. Bigot-
dc.contributor.googleauthorC. Nobre-
dc.contributor.googleauthorA. Tangpeerachaikul-
dc.contributor.googleauthorH.E. Pelish-
dc.contributor.googleauthorL. Friboulet-
dc.contributor.googleauthorJ. Lee-
dc.contributor.googleauthorB. Cho-
dc.contributor.googleauthorA.N. Hata-
dc.identifier.doi10.1016/S0959-8049(22)01008-5-
dc.contributor.localIdA03822-
dc.relation.journalcodeJ00809-
dc.identifier.eissn1879-0852-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0959804922010085-
dc.contributor.alternativeNameCho, Byoung Chul-
dc.contributor.affiliatedAuthor조병철-
dc.citation.volume174-
dc.citation.startPageS78-
dc.citation.endPageS79-
dc.identifier.bibliographicCitationEUROPEAN JOURNAL OF CANCER, Vol.174 : S78-S79, 2022-10-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.